BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19248972)

  • 41. Medical treatment of gastrointestinal stromal tumors: state of the art and future perspectives.
    Apice G; Milano A; Bruni GS; Iaffaioli RV; Caponigro F
    Rev Recent Clin Trials; 2006 Jan; 1(1):35-42. PubMed ID: 18393778
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A USA registry of gastrointestinal stromal tumor patients: changes in practice over time and differences between community and academic practices.
    Pisters PWT; Blanke CD; von Mehren M; Picus J; Sirulnik A; Stealey E; Trent JC;
    Ann Oncol; 2011 Nov; 22(11):2523-2529. PubMed ID: 21464155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of c-KIT oncoprotein in gastrointestinal stromal tumors in adults and children: guideline for diagnosis and treatment.
    Jankulovski N; Popov Z; Bojadzieva S; Validire P; Gogusev J
    Prilozi; 2006 Dec; 27(2):59-70. PubMed ID: 17211292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term survival of a case with multiple liver metastases from duodenal gastrointestinal stromal tumor drastically reduced by the treatment with imatinib and hepatectomy.
    Sakakura C; Hagiwara A; Soga K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yamaoka N; Sagara Y; Yamagishi H
    World J Gastroenterol; 2006 May; 12(17):2793-7. PubMed ID: 16718773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. C-kit, GIST, and imatinib.
    Siehl J; Thiel E
    Recent Results Cancer Res; 2007; 176():145-51. PubMed ID: 17607922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor.
    Heinrich MC; Maki RG; Corless CL; Antonescu CR; Harlow A; Griffith D; Town A; McKinley A; Ou WB; Fletcher JA; Fletcher CD; Huang X; Cohen DP; Baum CM; Demetri GD
    J Clin Oncol; 2008 Nov; 26(33):5352-9. PubMed ID: 18955458
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost effectiveness of tyrosine kinase inhibitor therapy in metastatic gastrointestinal stromal tumors.
    Blanke CD; Huse DM
    J Med Econ; 2010; 13(4):681-90. PubMed ID: 21067355
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disease progression following imatinib failure in gastrointestinal stromal tumors: role of surgical therapy.
    Jamali FR; Darwiche SS; El-Kinge N; Tawil A; Soweid AM
    Oncologist; 2007 Apr; 12(4):438-42. PubMed ID: 17470686
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of gastrointestinal stromal tumors in the era of tyrosine kinase inhibitors.
    George S; Desai J
    Curr Treat Options Oncol; 2002 Dec; 3(6):489-96. PubMed ID: 12392638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib.
    Bauer S; Hartmann JT; de Wit M; Lang H; Grabellus F; Antoch G; Niebel W; Erhard J; Ebeling P; Zeth M; Taeger G; Seeber S; Flasshove M; Schütte J
    Int J Cancer; 2005 Nov; 117(2):316-25. PubMed ID: 15900603
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Gastrointestinal stromal tumors].
    Ridolfini MP; Cassano A; Ricci R; Rotondi F; Berardi S; Cusumano G; Pacelli F; Doglietto GB
    Ann Ital Chir; 2011; 82(2):97-109. PubMed ID: 21688472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical and molecular characterization of gastrointestinal stromal tumors (GIST)].
    Mac K; Wójcik M
    Postepy Hig Med Dosw (Online); 2007 Jun; 62():272-81. PubMed ID: 18542042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gastrointestinal stromal tumor in a child and review of the literature.
    Hayashi Y; Okazaki T; Yamataka A; Yanai T; Yamashiro Y; Tsurumaru M; Kajiyama Y; Miyano T
    Pediatr Surg Int; 2005 Nov; 21(11):914-7. PubMed ID: 16240136
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A case of multiple metastatic giant rectal GIST successfully treated with surgical intervention after administration of imatinib mesylate].
    Kitamura D; Ikeda K; Unotoro J; Seki E; Gonda H; Izumi H
    Nihon Shokakibyo Gakkai Zasshi; 2013 Jan; 110(1):74-80. PubMed ID: 23303232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden.
    Nilsson B; Bümming P; Meis-Kindblom JM; Odén A; Dortok A; Gustavsson B; Sablinska K; Kindblom LG
    Cancer; 2005 Feb; 103(4):821-9. PubMed ID: 15648083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors.
    Agaram NP; Wong GC; Guo T; Maki RG; Singer S; Dematteo RP; Besmer P; Antonescu CR
    Genes Chromosomes Cancer; 2008 Oct; 47(10):853-9. PubMed ID: 18615679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Imatinib and gastrointestinal stromal tumor (GIST): a selective targeted therapy.
    Fernández A; Aparicio J
    Rev Esp Enferm Dig; 2004 Oct; 96(10):723-6; 727-9. PubMed ID: 15537379
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.
    Blay JY; Bonvalot S; Casali P; Choi H; Debiec-Richter M; Dei Tos AP; Emile JF; Gronchi A; Hogendoorn PC; Joensuu H; Le Cesne A; McClure J; Maurel J; Nupponen N; Ray-Coquard I; Reichardt P; Sciot R; Stroobants S; van Glabbeke M; van Oosterom A; Demetri GD;
    Ann Oncol; 2005 Apr; 16(4):566-78. PubMed ID: 15781488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group.
    Heinrich MC; Owzar K; Corless CL; Hollis D; Borden EC; Fletcher CD; Ryan CW; von Mehren M; Blanke CD; Rankin C; Benjamin RS; Bramwell VH; Demetri GD; Bertagnolli MM; Fletcher JA
    J Clin Oncol; 2008 Nov; 26(33):5360-7. PubMed ID: 18955451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gastrointestinal stromal tumor of stomach with inguinal lymph nodes metastasis: a case report.
    Zhang Q; Yu JW; Yang WL; Liu XS; Yu JR
    World J Gastroenterol; 2010 Apr; 16(14):1808-10. PubMed ID: 20380018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.